ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 929

Diurnal Variation of Power Doppler in Metacarpophalangeal Joints of Patients with Rheumatoid Arthritis

Marwin Gutierrez1, Emeline Minichiello2, Alarico Ariani1, Salima Challal2, Emilio Filippucci1, Marie-Christophe Boissier2,3,4, Walter Grassi1 and Luca Semerano2,3,4, 1Clinica Reumatologica, Università Politecnica delle Marche, Jesi, Italy, 2Service de Rhumatologie, Assistance Publique – Hôpitaux de Paris (AP-HP) Groupe hospitalier Avicenne - Jean Verdier – René Muret, Bobigny, France, 3Inserm UMR 1125, Bobigny, France, 4Sorbonne Paris Cité - Université Paris 13, Bobigny, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: rheumatoid arthritis (RA) and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Imaging of Rheumatic Diseases I: Ultrasound

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: In a preliminary study on 10 patients with active rheumatoid arthritis (RA) we showed for the first time that Power Doppler ultrasonography (PDUS) signal of metacarpophalangeal (MCP) joints has a clear diurnal variation. To test whether PDUS signal of MCP joints in RA patients actually varies according to the time of day, we undertook a larger study involving 50 patients with active RA

Methods: A total of 500 MCP joints from 50 patients with active RA were evaluated at three different times during the same day T1: between 7 and 10 a.m.; T2: 4-6 hours after T1; T3: 4-6 hours after T2. All joints were evaluated for both presence/absence of PDUS signal and according to a semiquantitative score (from 0 to 3). The results at T1, T2 and T3 were compared for each joint. The day of examination, factors that could potentially influence PDUS signal were avoided or controlled (smoke, alcohol, corticosteroids, NSAIDs, vasoactive drugs intake, room temperature, hand position). Within-patient PDUS score variation was quantified as the sum of the differences between PDUS scores in each joint at the three different examinations for each patient. Semiquantitive PDUS scores were compared with Friedman’s test. Categorical data (PDUS presence/absence) were compared with Cochran’s Q test

Results: Globally, 46 out of 50 patients (92%; CI : 84.48% to 99.52%) displayed some circadian variation of PDUS signal. There was a significant variation in the number of PDUS-positive MCP joints during the day (p<0.05), with more PDUS positive MCP joints at T0 (156) vs. T1 (144) and T2 (129) (p<0.05). Fifteen patients (30%; 95CI 17.3% to 42.7%) had at least one joint in which PDUS signal appeared or disappeared at different. Semiquantitative PDUS scores were significantly higher at T1 (p<0.05 vs. T2 and T3) with a subsequent reduction at T2 (p<0,05 vs. T1 and T3) and further reduction at T3 (p<0,05 vs. T1 and T2). This pattern of variation was not univocal and single patients and even single joints in the same patient could show higher scores at T2 or, more rarely, at T3.  Median within-patient PDUS score variation was 4 (range 0 to 34). Patients with higher than the median PDUS variation had higher DAS28 (p<0.05), but no higher CRP vs. those with lower variation.  Within-patient variation was moderately correlated with DAS28 (r=0.4, p=0.01) but not with CRP

Conclusion: PDUS signal varies significantly through the day, being higher in the morning and progressively lowering in early afternoon and evening. PDUS signal variation involved about 90% of patients, independent of disease activity. Patients with higher disease activity displayed greater variation of PDUS signal


Disclosure: M. Gutierrez, None; E. Minichiello, None; A. Ariani, None; S. Challal, None; E. Filippucci, None; M. C. Boissier, None; W. Grassi, None; L. Semerano, None.

To cite this abstract in AMA style:

Gutierrez M, Minichiello E, Ariani A, Challal S, Filippucci E, Boissier MC, Grassi W, Semerano L. Diurnal Variation of Power Doppler in Metacarpophalangeal Joints of Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/diurnal-variation-of-power-doppler-in-metacarpophalangeal-joints-of-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diurnal-variation-of-power-doppler-in-metacarpophalangeal-joints-of-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology